Sichuan Hebang Biotechnology Corporation Limited (603077.SS) released a profit for its first quarter that Increased, from last year
The company's bottom line came in at RMB173.589 million, or RMB0.0169 per share. This compares with RMB12.517 million, or RMB0.0012 per share, last year.
The company's revenue for the period fell 19.6% to RMB1.387 billion from RMB1.725 billion last year.
Sichuan Hebang Biotechnology Corporation Limited earnings at a glance (GAAP) :
-Earnings: RMB173.589 Mln. vs. RMB12.517 Mln. last year.-EPS: RMB0.0169 vs. RMB0.0012 last year.-Revenue: RMB1.387 Bln vs. RMB1.725 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.